<DOC>
	<DOCNO>NCT02189928</DOCNO>
	<brief_summary>Cerebral infarction common form stroke ( 80 % stroke ) . Stroke first cause acquire disability , 2nd cause dementia death . The approved treatment first 4.5 hour intravenous rt-PA thrombolysis ( Actilyse ® ) whose objective recanalization occlude artery reperfusion brain parenchyma . Few patient treat ( 1-5 % ) keep disability 50-60 % case . This handicap mainly correlate final infarct size . The objective neuroprotective treatment reduce final size cerebral infarction . The per-conditioning remote ischemic ( Per-CID ) show neuroprotective effect cerebral ischemia reduce final size cerebral infarction animal model . The per-CID corresponds , case cerebral ischemia , iterative ischemia realization member cuff . In human , per-CID show cardioprotective effect randomize control trial involve 250 patient within 6 first hour myocardial infarction candidate primary angioplasty .</brief_summary>
	<brief_title>REmote iSchemic Conditioning acUtE BRAin INfarction Study</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Patients ≥ 18 year Carotid ischemic stroke NIHSS score 5 25 Brain MRI perform within 6 hour symptom onset Obtaining write informed consent patient third party ( parent close ) , emergency inclusion process Affiliated Medicare ( rightful beneficiary ) Presence leg ulcer bad skin condition lower limbs History arterial occlusive disease lower limbs Sickle cell disease know ( risk vasoocclusive crisis ) History phlebitis lower limbs History cerebral infarction old 3 month Participation another interventional acute phase protocol Patients guardianship Pathologies involve lifethreatening within 6 month make impossible evaluate 3 month Patient nonself ischemic stroke ( Rankin Score previous &gt; 2 ) Pregnant Women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>